Owner Novartis AG

Inventors Bryan, Burkley; Damon, Robert Edson; Hughes, Thomas Edward

Agent Davies Collison Cave

Pub. Number AU-A-2007201989

Parent 2003209745

Filing date 4 May 2007

Wipo publication date 24 May 2007

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/015 (2006.01)

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/175 (2006.01)

A61K 31/198 (2006.01)

A61K 31/21 (2006.01) - Esters, e.g. nitroglycerine, selenocyanates

A61K 31/22 (2006.01)

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/401 (2006.01) - Proline

A61K 31/4035 (2006.01)

A61K 31/404 (2006.01)

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 31/4439 (2006.01)

A61K 31/4453 (2006.01) - only substituted in position 1, e.g. propipocaine, diperodon

A61K 31/47 (2006.01) - Quinolines

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/5415 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

A61K 31/64 (2006.01) - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system